Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Looking for participantsNCT02734537What this trial is testingRadiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryWho this might be right forHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+13 more ECOG-ACRIN Cancer Research Group 189
Not applicableStudy completedNCT00896896What this trial is testingImmunoreactivity to Cetuximab in Cancer PatientsWho this might be right forColorectal CancerHead and Neck Cancer Vanderbilt-Ingram Cancer Center 538
Testing effectiveness (Phase 2)Study completedNCT00005087What this trial is testingPaclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 105
Early research (Phase 1)Study completedNCT00404339What this trial is testingVaccine Therapy in Treating Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer Robert Ferris 17
Testing effectiveness (Phase 2)Study completedNCT00022594What this trial is testingLiposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Ended earlyNCT05316688What this trial is testingA Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During SurgeryWho this might be right forOral Cavity Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8+2 more University of Washington 8
Large-scale testing (Phase 3)Study completedNCT00002476What this trial is testingRadiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Cancer Research UK
Testing effectiveness (Phase 2)Study completedNCT00003582What this trial is testingRadiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerWho this might be right forCarcinoma of Unknown PrimaryHead and Neck Cancer University of Miami 36
Not applicableLooking for participantsNCT00898638What this trial is testingTissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 8,000
Early research (Phase 1)Active Not RecruitingNCT04533750What this trial is testingTesting the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hypopharyngeal Squamous Cell CarcinomaAdvanced Laryngeal Squamous Cell Carcinoma+15 more National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Not applicableStudy completedNCT03032250What this trial is testingPrepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck CancerWho this might be right forCaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell Carcinoma+35 more Wake Forest University Health Sciences 35
Large-scale testing (Phase 3)Study completedNCT00003888What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC 359
Not applicableStudy completedNCT01504932What this trial is testingFreeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer SurvivorsWho this might be right forStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage I Squamous Cell Carcinoma of the OropharynxStage I Verrucous Carcinoma of the Oral Cavity+16 more Ohio State University Comprehensive Cancer Center 42
Not applicableStudy completedNCT00809016What this trial is testingPET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation TherapyWho this might be right forHead and Neck Cancer Centre Oscar Lambret 40
Testing effectiveness (Phase 2)WithdrawnNCT06084845What this trial is testingTesting the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+12 more ECOG-ACRIN Cancer Research Group
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00352105What this trial is testingCisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer David Adelstein 60